Flu vaccines and antivirals - handle with care!
This article was originally published in Scrip
Executive Summary
The "risk-based approach" is gaining ground, and for good reason. As concerns continue over safety and quality issues, and pharmaceutical manufacturing and testing become increasingly globalised, regulatory authorities around the world are having to become more selective in how they address safety issues.